About FASI

Our Impact

FASI’s impact reaches beyond any single discovery. FASI has advanced what science knows about food allergy, how researchers study it, and what they can pursue next. Our impact reaches across the field, strengthening the foundation for better diagnosis, treatment, and prevention and opening new possibilities for people living with food allergy.

FASI Latest News

  • FASI and InBio Partner to Accelerate Food Allergy Research
  • VIEWPOINT: We Need To Demand More Alpha-Gal Research
more FASI news

2026

A Decade of Discovery:
Accelerating What Comes Next

Ten years of FASI’s bold questions and collaborative research have expanded what scientists understand today about food allergy. In 2026, their team built on that foundation by moving promising discoveries toward new ways to diagnose, prevent, and treat the disease. With stronger tools, growing partnerships, and new studies underway, the path to better care and the hope for a cure is becoming clearer.

2025

Opening a New Path to Treatment

FASI expanded its research in 2025, uncovering new clues about how the skin, brain, gut, and immune system work together in food allergy. For the first time, FASI launched a drug discovery program, creating a clearer path for turning these findings into potential treatments. Together, these advances opened a promising new chapter in food allergy research.

read the 2025 Impact Report

Financials & Reporting

2025 Audited Financial Statements 

2025 IRS Form 990

2024 Impact Report

2024 Audited Financial Statements

2024 IRS Form 990

2023 Impact Report

2023 Audited Financial Statements

2023 Organizational Efficiency

2023 IRS Form 990

2022 Audited Financial Statements

2022 Organizational Efficiency

2022 IRS Form 990

Recent FASI News

  • FASI and InBio Partner to Accelerate Food Allergy Research
    September 29, 2026
    Collaboration Brings High-Quality Materials and Specialized Capabilities to Drug Discovery Pipeline CAMBRIDGE, Mass. – The Food Allergy Science Initiative (FASI) and InBio announced today a partnership that will help accelerate the future of food allergy research….
    Read More
  • VIEWPOINT: We Need To Demand More Alpha-Gal Research
    September 21, 2026
    By Dr. Christine Olsen Cases of Alpha Gal Syndrome (AGS) are exploding around the country, with the Hamptons as an epicenter, according to the Centers for Disease Control and Prevention. There were more than 3,700…
    Read More
  • The next step in fighting allergies
    September 16, 2026
    By Carlos Bosques, Ph.D. I read with great interest Michael J. Coren’s Sept. 9 Health column, “Schools should stop banning peanuts. Here’s what really keeps kids safe,” on evolving school-based strategies for managing peanut and…
    Read More
  • Nature Paper: Breast Milk and Formula Nutrients are Processed by Gut Bacteria to Train the Immune System
    July 23, 2026
    Yale Professor and Food Allergy Science Initiative Principal Investigator Finds Possible Link Between Breast Milk Bacteria and Increased Immune Defenses
    Read More
  • Food Allergy Science Initiative and Vie Ventures Announce Strategic Collaboration to Accelerate Progress Toward a Cure for Food Allergies
    June 23, 2026
    The Food Allergy Science Initiative (FASI) today announced that it has joined Vie Ventures as a strategic collaborator.
    Read More
View All Articles